跳至主要内容
临床试验/NCT01720381
NCT01720381已完成不适用

Manual vs. Automated moNitoring Accuracy of GlucosE II (MANAGE II)

OptiScan Biomedical Corporation1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2012年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
98
试验地点
1
主要终点
Glucose Prediction error

研究概览

简要总结

The study is to demonstrate the accuracy of the OptiScanner in measuring blood glucose levels in critically ill patients when compared to a reference YSI 2300 STAT Plus and the Gem 3000, the reference standard for Erasme University Hospital.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed Informed consent.
  • Age ≥ 18 years.
  • Admitted to the ICU of Erasme University Hospital.
  • Expected ICU stay of ≥ 3 days at the time of enrollment (as judged by the Principle Investigator).
  • APACHE II score of ≥ 10, within the first 24 hours of ICU admission.
  • Existing central venous catheter + arterial catheter.
  • No participation in any other investigational interventional study while enrolled in this study.
  • Hyperglycemia (BG > 150 mg/dl) at the time of admission.

排除标准

  • Pregnancy.

结局指标

主要结局

Glucose Prediction error

时间窗: 1 year

Percent (%) predicted error is the percent (%) error result of the OptiScanner on central venous blood from the superior cava versus the YSI and the GEM using arterial blood.

次要结局

  • Clarke Error Grid analysis(1 year)

研究者

发起方
OptiScan Biomedical Corporation
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验